Harnessing γδ T cells in anticancer immunotherapy

This publication has 81 references indexed in Scilit:

• Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
  British Journal of Cancer, 2011
• Immune parameters affecting the efficacy of chemotherapeutic regimens
  Nature Reviews Clinical Oncology, 2011
• First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
  The Lancet, 2010
• A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells☆☆☆
  European Journal of Cardio-Thoracic Surgery, 2010
• Adoptively transferred ex vivo expanded γδ-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer
  Breast Cancer Research and Treatment, 2009
• Immunogenic and tolerogenic cell death
  Nature Reviews Immunology, 2009
• Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death
  The EMBO Journal, 2009
• Thymic Selection Determines γδ T Cell Effector Fate: Antigen-Naive Cells Make Interleukin-17 and Antigen-Experienced Cells Make Interferon γ
  Immunity, 2008
• Immunological aspects of cancer chemotherapy
  Nature Reviews Immunology, 2008
• Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
  Nature Medicine, 2007